| Literature DB >> 35494720 |
Yang Fan1, Zongming Li1, Jun Xi1.
Abstract
Aristolochic acids (AAs) have attracted significant attention because they have been proven to be the culprits in the mass incidents of AA nephropathy that occurred in Belgium in 1993. From then on, the door to sales of medicines containing AAs has been closed. As aristolochic acid (AA)-containing traditional Chinese medicine (TCM) has a potent therapeutic effect on some diseases, research into detoxication techniques for AA-containing traditional Chinese medicines (TCMs) should be considered to be absolutely essential. Therefore, in this paper, the use of AA-containing TCMs has been investigated and detoxication techniques, such as, processing (Paozhi, Chinese name), compatibility (Peiwu, Chinese name), pressurized liquid extraction (PLE) and supercritical fluid extraction (SFE), have been reviewed in detail. A large number of relevant studies have been reviewed and it was found that processing with honey or alkaline salts is the most widely used method in practical production. As the AAs are a group of weak acids, relatively speaking, processing with alkaline salts can achieve a high rate of reduction of the AAs. Meanwhile, it is necessary to consider the compatibility of AA-containing TCMs and other herbal medicines. In addition, PLE and SFE can also achieve an excellent reducing rate for AAs in a much shorter processing time. Therefore, the promotion of alkaline salt processing technology should be strengthened in the future. At the same time, some advanced modern extraction technologies also have good potential and should be further studied. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35494720 PMCID: PMC9048270 DOI: 10.1039/c9ra08327h
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Eight typical AA-containing TCMs.
Three AA-containing TCMs still being recorded in China pharmacopoeia
| English name | Chinese name | Species (name given in original sources) | Genus | Family | Part used | Main chemical composition | Illness or function | Usage |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| Aristolochiaceae | Stem | Aristolochic acid D, magnoflorine, β-sitosterol | Abdominal pain, joint pain, edema in pregnancy | Oral: 4.5–9 g |
|
|
|
| Aristolochiaceae | Fruit | β-Sitosterol, magnoflorine, aristolochic acid A (in seed), aristolochic acid C, aristolochic acid D, aristolactone | Antitussive, expectorant, hemorrhoids | Oral: decoction 3–9 g | |
|
|
|
|
| Aristolochiaceae | Roots and rhizomes | Asarinin, volatile oil (methyl eugenol, croweacin, asaricin and so on), aristolochic acid | Cold, sore throat, headache | Oral: decoction 1.5–9 g, powder: 1–3 g. external |
Fig. 2The morphology of the entire herb of Asarum (A) and Aristolochia debilis (B) recorded in the ancient book. Images showing Asarum in reality (C); processed Asarum used in medicine (D); the fruit of Aristolochia debilis (Ma Dou Ling) in reality (E); the processed fruit used in medicine (F); the stem of Aristolochia debilis (Tian Xian Teng) in reality (G); and the processed stem used in medicine (H).
Fig. 3The molecular structure of AA-I and AA-II.
Fig. 4The metabolic pathways of AA-I in vivo.
The reducing rate of AA-I in processed AA-containing TCMsa
| Herb | Species | Excipient | Proportion | Processing method | Time | Reducing rate of AA-I in decoction | Ref. |
|---|---|---|---|---|---|---|---|
|
|
| Yellow rice wine | 1 : 0.2 | Soaking | Until dry | 17.4% | Liu[ |
| Vinegar | 1 : 0.3 | Soaking | 2.89% | ||||
| Ginger juice | 1 : 0.1 | Soaking | 5.53% | ||||
| Honey | 1 : 0.24 | Soaking | 13.06% | ||||
| 0.1 mol L−1 NaHCO3 | Abundant excipient | Soaking | 3 d | 57.12% | |||
|
|
| Honey | 1 : 0.25 | Stirring | 15 min | 26.4–29.2% | Liang |
| 1 : 0.3 | Ultrasonic treatment | 1 h | 16.9–51.7% (AAAs), 32.7% (AA-I) | Li | |||
| Abundant excipient | Stirring | 25 min | 40–50% | Zhang | |||
| CAM | 0.1 mol L−1 NaHCO3 | 1 : 10 | Soaking | 5 d | 93.60% | Wang and Zhang[ | |
| Coptis | 1 : 1 | Plenty | 74.10% | Wu | |||
| Poria cocos | 23.39% | ||||||
| Cortex Moutan | Boiling | 19.20% | Wang and Deng[ | ||||
| Ultrasonic treatment | 50 min | 75.19% | Zhu[ | ||||
| Glycyrrhiza juice | Boiling | 2 h | 36.10% | Lu and Pan[ | |||
| NaHCO3 | 46.40% | ||||||
|
| 85.52% | ||||||
| Frutus Gardeniae | 1 : 1 | 57.49% | |||||
| Poria cocos | 23.39% | ||||||
| Coptis chinensis | 1 : 1.5 | Ultrasonic treatment | 30 min | 75.85% | Ma | ||
| 0.1 mol L−1 NaHCO3 | 1 : 10 | Soaking | 3 d | 84.70% | Lu and Pan[ | ||
|
| Boiling | 50 min | 48.47% | Xu and Xie[ | |||
| Ethanol | 1 : 2 | SFE | 12 h | 81.30%, 81.20% (AA-II) | Liang | ||
| FA | 65.20%, 59.10% (AA-II) | ||||||
| RA | Methanol | 1 : 20 | PLE | Rapid | 1080 mg kg−1 | Ong[ | |
| 1 : 20 | Ultrasonic | 30 min | 1018 mg kg−1 | ||||
| 1 : 100 | Soxhlet extraction | 7–8 h | 937 mg kg−1 |
CAM: Caulis Aristolochiae Manshuriensis; FA: Fructus Aristolochiae; RA: Radix Aristolochiae.
Fig. 5The basic procedure of Paozhi for AA-containing TCMs.
Some metabolic parameters of crude and processed Caulis Aristolochiae Manshuriensis and the acute toxicity of Fructus Aristolochiae and Radix Aristolochiae in ratsa
| Herb | Material | Dosage | Duration | Serum creatinine (Scr, μmol L−1) | Blood urea nitrogen (BUN, mmol L−1) | Urine protein (uPro, mg) | Urine volume (UV, mL) | Ref. |
|---|---|---|---|---|---|---|---|---|
| CAM | Crude CAM | 6 g kg−1 d−1 | 8 weeks | 57.91 ± 11.81 | 7.58 ± 2.61 | 9.10 ± 1.70 | Xie and Zhang[ | |
| Longdanxiegan | 57.91 ± 11.81 | 6.07 ± 0.55 | 6.15 ± 2.07 | |||||
| Blank | 7 d | 30.85 ± 4.05 | 6.25 ± 1.25 (30d), 6.18 ± 1.10 (90d) | — | 10–15 | Liu | ||
| Crude CAM | 3 g kg−1 d−1 | 65.06 ± 4.50 | — | 5–6 | ||||
| 0.5 g kg−1 d−1 | 31.20 ± 3.08 | 6.80 ± 1.56 (30d), 7.80 ± 1.60 (90d) | — | 10–15 | ||||
| Blank | 56.90 ± 1.70 | 5.86 ± 1.13 | 0.91 ± 0.34 | 6.01 ± 3.52 | Zhu | |||
| Crude CAM | 6 g kg−1 d−1 | 3 d | 65.34 ± 0.25 | 10.21 ± 0.89 | 2.05 ± 0.51 | 8.28 ± 1.21 | ||
| 7 d | 78.35 ± 1.43 | 18.92 ± 1.13 | 5.28 ± 2.41 | 12.11 ± 2.42 | ||||
| 15 d | 94.56 ± 1.51 | 26.42 ± 1.49 | 6.92 ± 1.92 | 10.65 ± 2.52 | ||||
| CAM and liquorice (LE) | 6 g kg−1 d−1 (CAM) + 2 g kg−1 d−1 (LE) | 3 d | 69.42 ± 2.35 | 13.14 ± 1.32 | 3.29 ± 0.21 | 11.31 ± 1.02 | ||
| 7 d | 82.49 ± 2.31 | 21.92 ± 0.98 | 6.31 ± 1.99 | 14.11 ± 1.92 | ||||
| 15 d | 99.66 ± 2.32 | 29.32 ± 1.03 | 9.14 ± 2.02 | 13.64 ± 2.02 | ||||
| Blank | 7 d | 181.11 ± 23.88 | 16.33 ± 2.34 | 6.01 ± 1.29 | 11.50 ± 1.31 | Li | ||
| Crude CAM | 12 g kg−1 d−1 | 244.38 ± 49.50 | 23.83 ± 3.71 | 9.68 ± 1.49 | 18.73 ± 4.82 | |||
|
| 6 g kg−1 d−1 | 182.13 ± 14.11 | 16.75 ± 1.16 | 6.13 ± 1.21 | 10.56 ± 1.71 | |||
| 12 g kg−1 d−1 | 192.10 ± 15.80 | 19.38 ± 1.59 | 7.32 ± 1.74 | 13.96 ± 4.92 | ||||
| 24 g kg−1 d−1 | 232.63 ± 12.22 | 24.13 ± 4.25 | 9.29 ± 1.95 | 27.85 ± 7.32 | ||||
| FA | Crude FA | (34.1 ± 7.2) g kg−1 d−1 (LD50) | Yang | |||||
| FA processed with honey | (62.6 ± 8.0) g kg−1 d−1 (LD50) | |||||||
| RA | Crude RA | 146.45 g kg−1 d−1 (LD50) | Jiang | |||||
| Processed RA | 846.06 g kg−1 d−1 (LD50) |
The decoction was given orally to healthy SD rats, female, 160–200 g. CAM: Caulis Aristolochiae Manshuriensis; FA: Fructus Aristolochiae; RA: Radix Aristolochiae.
Fig. 6The structure and procedure of a PLE system (A), and a schematic description of the procedure (B).
Fig. 7The structure and procedure of an SFE system (A), and a schematic description of the procedure (B).